Can an Aspirin a Day Keep Dementia at Bay?

CME : 0.25 + more
Start Date :  May 22, 2020End Date :  May 22, 2021

Organized by :   Medscape, LLC

Specialties :   Neurology, Psychiatry

Fees Fee :   Starting From Free

Conference Summary

Can an Aspirin a Day Keep Dementia at Bay? is organized by Medscape, LLC.

CME / ABIM MOC / CE Released: 5/22/2020
Valid for credit through: 5/22/2021

Accreditation:
For Physicians

Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For Nurses
Awarded 0.25 contact hour(s) of continuing nursing education for RNs and APNs; 0.25 contact hours are in the area of pharmacology.

For Pharmacists
Medscape, LLC designates this continuing education activity for 0.25 contact hour(s) (0.025 CEUs) (Universal Activity Number JA0007105-0000-20-077-H01-P). 

IPCE - 0.25 Interprofessional Continuing Education (IPCE) credit

Goal Statement:
The goal of this activity is to provide medical news to primary care clinicians and other healthcare professionals in order to enhance patient care.

Upon completion of this activity, participants will be able to:
• Evaluate the effect of low-dose aspirin vs placebo on incident all-cause dementia, Alzheimer disease, mild cognitive impairment, and cognitive decline in older individuals in the United States and Australia, based on an analysis from the Aspirin in Reducing Events in the Elderly double-blind, placebo-controlled trial
• Assess the clinical implications of the effect of low-dose aspirin vs placebo on incident all-cause dementia, Alzheimer disease, mild cognitive impairment, and cognitive decline in older individuals in the United States and Australia, based on an analysis from the Aspirin in Reducing Events in the Elderly trial
• Outline implications for the healthcare team

Topic
✔Dementia
  Dementia
✔Pharmacology education
  Pharmacology education
✔Professional Responsibility
  Professional Responsibility
Credit Info

  • CME : 0.25
  • MOC : 0.25
  • Contact Hours : 0.25
  • CEUs : 0.025
  • IPCE : 0.25
Contact Us

Toll free Number

1(800) 826-2059

Email

support@eMedEvents.com

Chat Assistant

Live Chat
Recommended